|
Delaware
|
| |
2836
|
| |
38-3982704
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer Identification No.)
|
|
|
Yvan-Claude Pierre
Marianne C. Sarrazin Pia Kaur Cooley LLP 1114 Avenue of the Americas New York, New York 10036 (212) 479-6000 |
| |
Lawrence A. Kenyon
Outlook Therapeutics, Inc. 7 Clarke Drive Cranbury, New Jersey 08512 (609) 619-3990 |
| |
Jack Hogoboom
Lowenstein Sandler LLP 1251 Avenue of the Americas New York, NY 10020 (212) 262-6700 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | | | Non-accelerated filer ☐ | | | Smaller reporting company ☒ | |
| | | | | | | | | | Emerging growth company ☒ | |
| | |
Amount
|
| |||
SEC registration fee
|
| | | $ | 6,969 | | |
FINRA filing fee
|
| | | | 8,625 | | |
Accountant’s fees and expenses
|
| | | | 100,000 | | |
Legal fees and expenses
|
| | | | 400,000 | | |
Transfer agent’s fees and expenses
|
| | | | 5,000 | | |
Printing and engraving expenses
|
| | | | 30,000 | | |
Miscellaneous
|
| | | | 9,406 | | |
Total expenses
|
| | | $ | 560,000 | | |
|
Signatures
|
| |
Title
|
| |
Date
|
|
*
Ralph H. Thurman
|
| | Executive Chairman | | |
April 2, 2019
|
|
/s/ Lawrence A. Kenyon
Lawrence A. Kenyon
|
| | President and Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director (Principal Executive, Financial and Accounting Officer) |
| |
April 2, 2019
|
|
*
Yezan Haddadin
|
| | Director | | |
April 2, 2019
|
|
*
Kurt J. Hilzinger
|
| | Director | | |
April 2, 2019
|
|
*
Pankaj Mohan, Ph.D.
|
| | Director | | |
April 2, 2019
|
|
*
Faisal G. Sukhtian
|
| | Director | | |
April 2, 2019
|
|
*
Joe Thomas
|
| | Director | | |
April 2, 2019
|
|
*
Joerg Windisch, Ph.D.
|
| | Director | | |
April 2, 2019
|
|
* By: /s/ Lawrence A. Kenyon
Lawrence A. Kenyon
Attorney-in-Fact |
| | |